Source: Annual Congress 2011 - COPD diagnosis



Rating:

Share or cite this content

Citations should be made in the following way:
S. Langwieler, T. Wex, M. Peter, J. Schreiber (Magdeburg, Magdebuerg, Germany). Impairment of membranous and vascular components of pulmonary diffusion and plasma endothelin-1 in patients with liver cirrhosis with and without COPD. Eur Respir J 2011; 38: Suppl. 55, 3570

Member's Comments

No comment yet.

Related content which might interest you: Endothelin-1 level and central arterial stiffness in patients with COPD and hepatic cirrhosis Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Association between diffusion capacity and endothelial function in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems Year: 2018 Role of IL-11 in vascular function of pulmonary fibrosis patients Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Arterial stiffness and endothelial dysfunction in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Pulmonary vascular changes in COPD and idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2006 - Clinical physiology Year: 2006 Endogenous and nitrovasodilator-induced release of NO in the airways of end-stage cystic fibrosis patients Source: Eur Respir J 2010; 36: 682-683 Year: 2010 Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007 PP309 – Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis Source: ERS Lung Science Conference 2021 Year: 2021 Time-course changes in pulmonary haemodynamics in patients with idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation (LT) Source: Eur Respir J 2004; 24: Suppl. 48, 668s Year: 2004 Association between endothelial function and pulmonary function in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Evaluation of pulmonary function and functional capacity in patients with liver cirrhosis Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Increased polysialylation in lung tissue of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant Source: Eur Respir J 2007; 30: 715-721 Year: 2007 Endothelin-1 level of functional tests and arterial deoxygenation in patients with COPD and cirrhosis Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Correction of endothelial dysfunction in patients with COPD, IPF Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Pulmonary vascular and cardiac impairment in interstitial lung disease Source: Eur Respir Rev 2017; 26: 160128 Year: 2017 Reduced pulmonary vascular response to hypoxia is associated with endothelial dysfunction in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 173s Year: 2001 Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations Source: Eur Respir Rev 2014; 23: 350-355 Year: 2014